Introduction

▼
Ultrasonography has become a widespread diagnostic tool available to most general practitioners and internists. Whether used for a specific diagnostic or a preventive workup, it may yield information that goes beyond the specific question asked. One example of great impact is the chance finding of atherosclerosis which may be a sign of developing cardiovascular disease. In recent years an increasing prevalence of hepatic steatosis has been noticed. It is well established that hepatic steatosis is associated with risk factors for atherosclerosis, particularly type 2 diabetes and the components of the metabolic syndrome [1, 2] . In several studies and various populations an association between non-alcoholic fatty liver disease (NAFLD) and surrogates of cardiovascular disease has been observed [3] . Increasingly hepatic steatosis becomes a chance finding, which has been shown to be associated with cardiovascular risk factors, surrogates of vascular disease, and vascular events. This study tries to answer the question whether it is justified to recommend a cardiovascular workup in response to the incidental finding of hepatic steatosis in asymptomatic healthy individuals.
Methods:
The data of 259 healthy women and 561 men aged 19-93 years, who consecutively underwent a primary preventive check-up, were retrospectively analyzed. Ultrasonography for diagnosis of hepatic steatosis, determination of the maximal intima media thickness (IMT) and plaques of the carotid arteries was performed by a single certified physician according to conventional criteria.
Results: Hepatic steatosis was found in 28.3 % men and 7.7 % women. In 88 % the steatosis was judged to be mild. These individuals differed from those without hepatic steatosis in body mass index, ALAT, GGT, HbA1c, fasting glucose, triglycerides, HDL and lipoprotein(a). The IMT was higher and plaques were more prevalent.
In logistic regression analysis hepatic steatosis was a highly significant predictor of the presence of an IMT > 0.8 mm or carotid plaques besides age and sex. This was also the case in analyses including BMI, or multiple risk factors, which added only lipoprotein(a) as a predictor.
Conclusion:
The incidental diagnosis of hepatic steatosis is a strong indicator for the presence of cardiovascular risk factors and even signs of developing atherosclerosis. Thus, the recommendation of further cardiovascular workups seems appropriate.
metabolic syndrome. Targher et al. went even one step further and showed an increased risk for future cardiovascular events in patients with hepatic steatosis [5, 8] . This study intends to investigate into the potential of abdominal ultrasound to predict the prevalence of atherosclerosis in primarily healthy subjects. This may add to the question of whether it is justified and advisable to recommend a cardiovascular workup to patients with hepatic steatosis, despite no cardiovascular problems. For this purpose, the data of 820 primarily healthy individuals presenting with no acute symptoms in a preventive medical check-up setting were retrospectively analysed, and the association of hepatic steatosis diagnosed by ultrasonography with risk factors for atherosclerosis and increased carotid intima media thickness or plaques was evaluated. , and liver enzymes (aspartate aminotransferase (ASAT), alanine aminotransferase (ALAT), and gammaglutamyl transferase (GGT)). Hypertension was defined by a systolic blood pressure ≥ 140 mmHg or diastolic of ≥ 90 mmHg or being on antihypertensive therapy. Ultrasonographic investigations were performed by a single experienced and certified internist certified by the German association of ultrasound in medicine (DEGUM) level III using a high end device (Siemens Acuson Antares premium edition, Siemens, Erlangen, Germany) with a curved 2-6 MHz array for the abdominal organs and a linear 5-9 MHz array for the examination of the extracranial vessels and taking the maximum intima media thickness of the distal wall of one of the common carotid arteries.
Materials and Methods
▼
The diagnosis of hepatic steatosis by ultrasound was graded according to the criteria established by Joseph et al. 1991 [9] : "mild steatosis": slightly hyperechoic, but homogenous echo structure; "moderate steatosis": hyperechoic structure, dorsal diminishing of echo signal and beginning rarefication of hepatic vessels; "severe steatosis": hyperechoic and irregular parenchym structure, suspected fibrocirrhotic change, irregular margin and reduced elasticity. An abnormal intima media thickening refers to a maximal intima media thickness of > 0.8 mm of the far wall of the common carotid artery [10] [11] [12] . Plaques were defined as atheromatous, calcificated or mixed circumscribed wall thickenings, and stenoses were defined as wall irregularities taking more than 60 % of the vessel lumen graded according to Hennerici et al. [13] and Touboul et al. 2012 [14] . Statistical analyses were performed using the XLSTAT software 2012 (Addinsoft Germany). For comparing the prevalence of characteristics of individuals with (cases) or without (controls) a fatty liver, the Mann-Whitney test was applied for continuous parameters and the Chi-square test for discontinuous data. Multivariate analyses were performed by logistic regression. P-values of < 0.05 were regarded significant.
Results
▼
Data of 820 patients were analysed. The basic characteristics of 561 men and 259 women with (cases) or without (controls) hepatic steatosis as diagnosed by abdominal ultrasound are given in • ▶ Table 1 . In 154 men (28.3 %) and 20 women (7.7 %) hepatic steatosis was diagnosed by abdominal ultrasound. 88 % of these patients had mild steatosis [9] . Only 2 women and 18 men were judged to have moderate steatosis, and 1 man with severe hepatic steatosis was suspected to have fibrocirrhosis.
Cases and controls were of comparable age ( • ▶ Table 1 ). In line with the higher ultrasonographic classification of hepatic steatosis in cases, ALAT and GGT were also on average higher in both male and female cases than in controls ( • ▶ Table 2 ). Fasting glucose ≥ 100 mg/dl and hypertension were more prevalent in cases, though only in women the differences reached significance. An IMT of > 0.8 mm or plaques in the common carotid arteries were more prevalent in male cases (36.4 %) than in controls (29.0 %) (p = 0.092), yet the difference between cases (40.0 %) and controls (16.7 %) reached only significance in women (p = 0.001). Also, plaques in the common carotid arteries or bulbi were numerically more frequent in male cases (31.2 %) than in controls (24.1 %) (p = 0.088), and in female cases (40.0 %) and controls (16.7 %) (p = 0.438), which, however, did not reach significance in both genders. Even though elevated IMT has often been associated with fatty liver especially in men, it frequently occurred also in individuals without a fatty liver as well. Still, the logistic regression analysis revealed male sex and hepatic steatosis besides age as highly significant predictors of an IMT > 0.8 mm or the manifestation of carotid plaques detected by ultrasound. Excluding BMI from the analysis did not materially alter the results. In a multivariate analysis including major cardiovascular risk factors, besides age only hepatic steatosis and elevated lipoprotein(a) proved to be statistically significant predictors of the presence of elevated IMT or carotid plaques in both genders despite multiple adjustments ( • ▶ Table 3 ). Table 2 Frequency of pathological clinical and ultrasonographic parameters and the significance of their differences in individuals with and without hepatic steatosis diagnosed by ultrasonography.
Discussion
▼
The results of this study clearly indicate that hepatic steatosis as diagnosed by abdominal ultrasonography is a valid marker of developing atherosclerosis in otherwise healthy people in a preventive check-up setup: to our knowledge, this is the first study demonstrating this correlation in an outpatient population of otherwise healthy individuals. The multivariate analysis even implies that hepatic steatosis adds to the effects of the major cardiovascular risk factors. It has been suggested that cardiovascular disease is the most important factor of outcome in patients with non alcoholic fatty liver disease and determinates the life expectancy much more than the progression of liver disease itself. Not only intima media thickness is increased, but there is also an impairment of flow-mediated vasodilation [16] . It has been shown that the presence of non-alcoholic fatty liver disease diagnosed by ultrasound is independently associated with an increased prevalence of ischemic heart disease [17, 18] . The SHIP study, a large population based study in Northern Germany, showed in a 5-and 10-year follow-up that patients with a fatty liver had a significant higher morbidity and mortality than patients without this condition [19, 20] . Certainly, the cohort under investigation is not a representative population. However, this has been judged not to be necessary to answer the very practical question, whether it is sensible to recommend cardiovascular diagnostics based on the finding of hepatic steatosis in a thus far healthy population. Also, the accuracy of ultrasound for the detection of steatosis is not crucial in this respect, although it has been found reasonably specific [9, 21, 22] . The strength of this study is the retrospective design, since no study objective could have possibly prejudiced the results of the ultrasonographic investigation and examination bias is omitted. Furthermore, the scheduling in the center does not allow sharing knowledge with the investigator regarding results of laboratory values, cardiac echo or ECG at the time of the abdominal ultrasound.
In our study, hepatic steatosis diagnosed by abdominal ultrasound turned out to be stronger than any individual major cardiovascular risk factor, but for lipoprotein(a) to predict subclinical atherosclerosis of the carotid arteries. This is probably due to the fact that ectopic fat is a major causal factor for the components of the metabolic syndrome; thus, hepatic steatosis subsumes the effects of these factors similar to the definition of the metabolic syndrome [1, 2] . Moreover, ultrasound demonstrates the risk pattern to the patient in real time, not only by visualizing the fatty liver, but also displaying the developing atherosclerosis of abdominal vessels. Ultrasound is also very well-suited for follow-up exams to monitor the therapeutic success. Weight loss and physical exercise may induce normalization of liver tissue [23] . This is visually more impressive than the reduction of intima media thickness by 0.1 mm. So, based on this study and previous experience [24] , we think abdominal ultrasound to be appropriate in medical prevention, not only to evaluate the abdominal organs, but also to assess patients who are at a higher risk for cardiovascular diseases. In summary, detecting hepatic steatosis has a diagnostic impact on the choice of therapeutic measures for the prevention of cardiovascular disease by itself, though it seems appropriate to take hepatic steatosis as a call for further classification of the induced risk factors and the impact on the arterial wall. In conclusion, this study demonstrates that the incidental finding of hepatic steatosis is an appropriate indication for further cardiovascular work-ups in times of individualized medicine and prevention, especially in men. Table 3 Logistic regression of clinical parameters as to prediction of an intima media thickness > 0.8 mm in the common carotid arteries or plaques in the common carotid arteries or bulbi.
